Vitamin D sensitivity to the immune responses and autoimmunity: A
  chemical network model study by Roy, Susmita et al.
Vitamin D sensitivity to the immune responses and autoimmunity: A 
chemical network model study
Susmita Roy, Krishna Shrinivas and Biman Bagchi*
SSCU, Indian Institute of Science, Bangalore 560012, India.
(Email: profbiman@gmail.com)
Abstract
Although Vitamin D is believed to be involved in a large number of immune responses our 
understanding of these processes at cellular level  remained at infancy.  We develop and 
solve a coarse grained kinetic network model to quantify the effects of variation of vitamin 
D on human immunity. The system of equations accounts for known inter-relation between 
active and inactive vitamin D, antigen presenting cells, effector T cells, regulatory T cells  
and  pathogen.  Both  time  dependent  and  steady  state  solutions  are  obtained.  The  time 
dependent solution of the system of equations reveals that the immune response is rather 
strongly  regulated  in  presence  of  vitamin  D.  We found  quantitatively  that  lower  than 
optimum levels of concentration of active vitamin D correspond to weak regulation where, 
once a pathogen/antigen enters the body, the nature of the immune response would be less 
regulatory and hence more aggressive, or inflammatory. The steady state solution of our 
model  shows  that  vitamin  D  enhances  the  tolerance  level  of  immune  system,  thereby 
increasing  resistance  to  autoimmune  diseases.  Our  model  and  accompanied  numerical 
analyses  reveal  another  important  aspect  of  immunity:  While  extremely  low  levels  of 
vitamin D could lead to increased risk of autoimmune responses, an overdose (toxic) level 
would give rise to too large a tolerant response, leading to the increased risk of tumors and 
cancerous cell growth. 
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Introduction
Beyond the  well-known function  in  calcium metabolism it  is  now clear  that  vitamin  D 
deficiency  can  cause  several  chronic  diseases  including  autoimmune  diseases  and  cancer. 
Spurred by modern epidemiologic studies, efforts in the last two decades are being directed to 
understand the origin of non-classical immunomodulatory responses, triggered by active 1, 25-
dihydroxy vitamin D. Beyond its established classical function in calcium metabolism, studies on 
vitamin-D is now progressively focused for its pleiotropic actions. [1-6]
Several experimental and clinical studies have revealed that endogenously produced active 
vitamin D (1,25(OH)2D) in macrophages enhances the production rate of anti-microbial peptides 
(cathelicidin, β-defensins, etc), to promote the innate immunity. [7] Subsequently, the conversion 
of  25-D3 into  functional  1,  25-D3 [D*]  exerts  potent  effect  on  adaptive  immune  system.  It 
apparently slows down the functions of antigen-presenting cells (APCs), particularly of Dendritic 
cells (DC). [8] While active form of vitamin D severely affects T cell activation, proliferation 
and  differentiation,  it  facilitates  the  production  of  regulatory  T (Treg)  cells  that  can  indeed 
function as an effective immune controller. [9, 10]
Vitamin  D mediated  infections  remedial  therapies  have  been followed over  past  150 
years. Since early 1900s, usage of cod-liver oil and UV light became widely recognized as the 
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essential sources of vitamin-D. Therapeutic use of vitamin D first drew attention in 1849, when 
William found cord- liver oil in curing over 400 tuberculosis (TB) patients. [11] After a long 50 
years gap, Niels Finsen owned the Nobel prize by highlighting the medicinal approach of UV 
exposure by which he treated over 800 patients affected by lupus vulgaris (a cutaneous form of 
TB). [12, 13]  In Indian traditional Auyrvedic treatments,  use of sunlight to treat and reduce 
diseases goes back to several thousand years where it is referred to as “Suryavigyan” (Meaning: 
science of Sunlight).
We now briefly review the biochemistry of the processes involved in vitamin D. Vitamin 
D, a type of secosteroid can be ingested by humans as cholecalciferol (D3) or ergocalciferol 
(D2). Humans can also generate Vitamin D by converting cholesterol when exposed to sunlight. 
In fact,  this mechanism not only contributes to a significant percentage of the production of 
Vitamin D but also in maintaining serum levels through a feedback loop. The hormonally active 
form of Vitamin D is calcitriol (1, 25-dihydroxyvitamin D3). This generation of the active form 
is through multiple steps. The 1st step is the hydroxylation of the inactive Vitamin D3 in the liver 
to 25-hydroxyvitamin D3 (calcidiol). This is then converted to 1, 25-dihydroxyvitamin D3 via 
the  enzyme  (cytochrome  P450  monooxygenase  25(OH)D  1-α  hydroxylase  (CYP27B1; 
1α(OH)ase) mediated catalysis of 25-hydroxyvitamin D3 . [14] This enzyme is primarily found 
in the proximal renal tube. But the enzyme itself is upregulated and stabilized in various other 
cells, including leukocytes, macrophages and dendritic cells in presence of appropriate stimuli. 
Active  vitamin  D  (D*)  also  auto-regulates  its  synthesis  by  upregulating  the  enzyme  25-
Hydroxyvitamin  D3  24-hydroxylase  (CYP24A1),  which  hydoxlyates  both  Calcitriol  and 
Calcidiol into hormonally inactive forms. This enzyme (CYP24A1) is also a P450 cytochrome. 
[15]
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Most typical immune responses are divided into two arms: Innate response and adaptive 
response. Innate response involves a generic response against pathogens primarily referred by 
phagocytes and natural killer cells. In this response, macrophages and monocytes provide the 1st 
line of defense against the invading pathogens by phagocytosing the pathogen with the help of 
some receptors  (PAMPs).  [8]  Dendritic  cells  in  the Lymph node (mostly Myeloid  Dendritic 
Cells) serve to break down the pathogenic epitopic peptides and play a key role in activation of 
the adaptive response. Natural killer cells also kill pathogens, but not by direct phagocytosis of 
pathogen, but rather by killing virally infected cells. In contrary adaptive response is a specific 
pathogen based response which is triggered by activation of antigen specific T and B cells in 
jawed vertebrates. This response, though late to set in, not only serves to mitigate pathogenic 
growth but also renders the body with immunological memory, which helps in easier control of a 
particular  pathogenic  outbreak,  if  it  were  to  happen  again.  The  processes  of  somatic 
hypermutation  and some specific  (VDJ) recombination  help  in  expressing a  vast  number  of 
antigen receptors from a small number of genes. This essentially explains how the T and B cells 
can identify virtually almost any type of antigen. [16]
 Vitamin D and innate response:
Vitamin D plays a crucial role in the functioning of the innate immune system, both by 
aiding the killing of pathogens and regulating the process which triggers the adaptive response. 
An in-depth analysis follows:
Vitamin D is found to be a stimulant in the maturation of monocytes to macrophage-like 
phagocytosing  cells.  The  antimicrobial  activity  exhibited  by  these  Macrophages  is  highly 
4
dependent on the presence of active vitamin D (D*). The following is a point wise, sequential 
explanation of a macrophage response: (i) The pathogens exhibit certain epitopes which are used 
to  recognize  a  foreign  organism that  is  present.  These  generic  epitopes  are  called  Pathogen 
Associated  Molecular  Patterns  (PAMPs),  which  are  used  by  the  innate  immune  system  to 
respond against invading pathogens. (ii) There are Toll-like Receptors (TLR) that are present on 
the  surface  of  the  macrophage  cells  which  help  in  recognizing  these  PAMPs.  Once  this 
recognition process occurs, a biochemical cascade of events is triggered which ultimately leads 
to the death of the pathogen. (iii) The immediate response post TLR activation is the NF-κβ 
activation  through  the  MyD88  coupling  pathway.  [17]  This  leads  to  three  major  results: 
Upregulation  of  the  enzyme  CYP27B1  in  the  P450  cytochrome  and  upregulation  of  VDR 
expression.  Monokine synthetic response primarily includes release of interleukins 1β and 15. 
[18] (iv) Once the enzyme CYP27B1 is upregulated, there is increased local production of D* 
from inactive D3. Since VDR expression is also up-regulated, this also leads to the formation of 
more D*-V DR complexes. [D*] is regulated in two ways: 
(a) Autoregulation: As more D* is produced, the enzyme CYP24A1 is upregulated. This 
enzyme in turn inhibits formation of D* from inactive D3.
(b)  Ligand-Binding:  A  truncated  version  of  the  CYP24A1  enzyme  version  is  also 
present,i.e. CYP24A1-SV(Splice Variant). Despite being metabolically inactive, it can act as a 
decoy for D* or inactive D3 by binding with them in the steroid binding pockets. Molecular 
modeling suggestsscus this Splice Variant preferentially binds to inactive D3 suggesting that it 
acts as a decoy for inactive D3, reducing its availability to other enzymes. [18, 19]
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Vitamin-D and adaptive response:
   Myeloidic Dendritic Cells (DC) play an important role in activating the adaptive response. 
They are  also  known as  professional  Antigen  Presenting  Cells  (APC).  These  dendritic  cells 
phagocytose pathogens and present certain epitopes in the Major Histocompatibility Complex 
(MHC) molecule type II on the surface of the DC. This process through which a dendritic cell 
phagocytoses a pathogen and presents it on the surface as a MHC class II molecule is referred to 
as the maturation of the dendritic cell. Naive T cells which are produced in the Thymus gland are 
activated by coming in contact with a dendritic cell which presents a MHC class II type peptide. 
This process occurs in the lymph nodes. The process is quite complex, but can be understood as 
the basis for the activation of the pathogen-specific adaptive response. The basic activation step 
can be understood by understanding the process of T-cell activation. The chronological analysis 
of the event is described in the supplementary meterial [20].
D* concentration  affects  the  formation  of  different  type  of  helper  T cells.  The most 
prominent effect of [D*] is in the stimulation of production of IL-10. This leads to dual effect of 
increasing the Treg cell count but also inhibiting Th1 and Th17 cell proliferation. However the 
effect of vitamin D on Th2 is not yet clear. The Treg cells are positively regulated through the 
up-regulation of the CLTA-4 and FOX-P3 markers. [D*] also suppresses production of IFNγ, IL-
17, IL-21 and IL-22. This also suppresses proliferation of Th1 and Th17 type effector cells. 
Furthermore,  production of vitamin D is directly  enhanced by the formation of the activated 
effector  T  cells.  This  is  due  to  the  fact  that  the  CD40 bonding  upregulates  1-α  expression 
(CYP27B1) in the dendritic cells. Also, as mentioned above, vitamin D can down-regulate itself 
by up-regulating the enzyme CYP24A1 in the P450 cytochrome. [21-24]
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DCs are the central  linker  between innate  and adaptive  immune systems.  While  DC 
activation occurs through pattern-recognition receptor referred as innate response, in turn trigger 
the activation of adaptive immune network in a sequentially manner. [24]
Vitamin D and autoimmune diseases
Targeted  destruction  of  self-tissues  by  the  overly  active  immune system causes  various 
types  of  autoimmune diseases.  Autoimmunity  is  primarily  driven by enhanced number  of  T 
helper cells (Th1) that attack various self-tissues in the body. It is clear that both genetic and 
environmental  factors  affect  disease  prevalence.  However,  from  past  epidemiologic  data 
highlights the link between vitamin D insufficiency and a range of immune-mediated disorders 
have  emerged  in  parallel  with  experimental  studies  on  the  immunomodulatory  properties  of 
vitamin D. In particular the inhibitory effect of vitamin D on the effector T-cell responses and 
promoting Tregs, may, at least in part, have begun to explain some of these associations. [8, 25-
27].
In  the  present  article  we develop a  theoretical  coarse  grained kinetic  network  model 
model to explore quantitatively the dependence of immunity on vitamin D and how it could play 
an important role in reducing the risk of auto-immune diseases and cancer. We analyze several 
immunemodulatory issues that  essentially  controlled by vitamin D including both innate  and 
adaptive responses as articulated in several experimental reports and reviews. Though there are 
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numerous other complex biochemical  reactions involved in the immonological  pathways, we 
have considered only a certain number of them that involve important interaction with vitamin- 
D.  We  also  address  the  concern  for  optimal  vitamin  D  intake  raised  by  World  Health 
Organization‘s international agency for reasearch on cancer. Present study especially suggest that 
inhibitory action exerted by regulatory T-cell induced by vitamin D and by vitamin D itself on 
adaptive response play an important role in prevention of autoimmune diseases. 
The present  approach of network kinetic  model  building bears strong resemblance  to 
similar methods adopted routinely in the study of kinetics proof reading [28, 29] and in also 
enzyme  kinetics  [30-32].  In  all  these  studies,  precise  quantitative  prediction  is  hindered  by 
imperfect knowledge about the system parameters; especially values of rate constants are often 
not available. This lacuna is indeed a source of serious problem not only in study of kinetic proof 
reading, enzyme kinetics but also, as we find here, in theoretical investigations of immunology. 
Finally, master equations involved all such problems are solved essentially by employing the 
method of mean first passage time [29, 33], Gillespie algorithm or straight forward numerical 
integration. We adopt the last procedure here.
In the present study we have employed the parameter space scanning method to obtain 
their order of magnitude values. We believe that we are not missing any dynamical character of 
the system. However the present method we have employed is deterministic as we have ignored 
the necessary fluctuation evolved in the system. 
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Method
Coarse-graining of the reaction network
To understand the interplay among different types of immune cells, pathogens and the 
modulatory role of vitamin D, a simple coarse-grained approach needs to be developed. This is 
because biochemical machineries in the human body are highly coupled with each other and 
hence  leads  to  enormous  complexity.  Hence  understanding  the  relation  between  different 
machineries involving different types of cell requires high level of detailing at the molecular 
level.  A  simpler,  albeit  cruder  version  is  proposed  that  accounts  for  different  level  of 
complexities at the molecular levels by coarse-graining them at the cellular level. Subsequently 
we perform network analysis based on T-cell activation, deactivation ad regulation. Once the 
developed network appears to be simple enough, a system of coupled differential equations is 
used to model the system. Even our simpler model involves nine coupled equations which need 
to be solved numerically and, as shown below, exhibit rich dynamics.
We initially represent a complex, rather detailed model system based on the interaction 
network. This representation includes DC (dendritic cells) linker that essentially connects the 
innate and adaptive immune network.  The main proposed model is not at the molecular level 
encompassing MHC−II, but rather at the cellular level. This model primarily seeks to understand 
adaptive  response  activation  and  effect  of  vitamin  D  on  tolerance/regulatory  nature  of  the 
response. Hence we have emphasized over the regulatory function of vitamin D on adaptive 
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immune system considering a constant rate of pathogen killing by innate mechanism with the 
production of antimicrobial peptides leading the 1st defense against infectious diseases. 
The  important  constituents  considered  here  are  the  following:  (i) 
pathogen/antigen/epitope/self-Antigen, (ii) naive T-cell, (iii) myeloid dendritic dell in the form 
of professional antigen presenting cells (APC), (iv) effector/regulatory T cells,  (v) vitamin D 
(25(OH)D3),  (vi)  vitamin D receptor  (VDR) and (vii)  the enzyme 25(OH)D3-1a-hydroxylase 
(CYP27B1) that simultaneously function over inactive vitamin D to form activate  vitamin D 
(1,25(OH)2 D)-VDR protein complex. It is important to emphasize here that we have included 
the essential features of the adaptive responses mostly based on the interaction network proposed 
by Powri  and Maloy.  [34]  However  they  did  not  consider  or  include  the  important  role  of 
vitamin-D. In Figure 1 we have presented the complex interaction network model that includes 
various components and their inter-relation and regulation involved in the immune system.
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Figure 1:  A complex representation of adaptive response. 
In this network the events are the following: (i) In presence of pathogen APC become stimulated and  
induce the activation of effector T-cells that ultimately destroy the pathogen. (ii) The enhanced rate of 
active T-cells production is regulated by both regulatory T-cells (Treg) and active vitamin-D. (iii)  In  
behind regulatory T-cell function is upregulated by active vitamin-D either through membrane initiated 
interaction or through VDR mediated mechanism. (iv)In addition more regulatory T-cell leads to more 
resting APC that again leads to more regulatory T-cells. Similarly more effector T-cell leads to more 
active APC that again leads to more effector T-cells. The self feedback loop is of vitamin D is noted. We  
have not shown the precursor cells for APC or T-cells in this diagram. Note that here green arrows stand  
for upregulation and red arrows for inhibition.
It is well established that the primary molecular action of 1, 25(OH)2 D is to initiate gene 
transcription by binding to VDR which is a member of the steroid hormone receptor superfamily 
of ligand-activated transcription factors. VDR therefore is an important factor in 1, 25(OH)2 D 
mediated functions. More detailed information about the molecular activation of VDR and its 
role in gene transcription can be obtained from the recent review appraised by Pike et al. [35]
In contrary, we found that there are growing evidences that 1, 25(OH)2 D also has rapid 
actions that are not essentially mediated through transcriptional events involving VDR. They are 
in fact membrane initiated actions. [36]
 Our model is essentially based on the following observations:
(i) Myeloid Dendritic Cells (here we call them as antigen presenting cell (APC)) which 
circulate around the body are the key players involved in triggering the onset of an 
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adaptive  response.  While  pathogen  phagcytosed  Dendritic  cells  serve  to  activate 
naive T cells into effector T cells, immature Dendritic cells (APC) convert naive T 
cells into regulatory T cells. 
(ii) Naive T cells are circulated and produced in large quantities in the blood stream and 
using absolute amount of T cells is both ineffective and computationally expensive. 
Instead, only the antigen-specific naive T cells are considered in the model. Hereafter, 
when references are made to native T-cells, they only refer to antigen/epitope specific 
naive T cells. 
(iii)  Pathogen/Antigen has a birth rate which includes influx and proliferation rates and a 
death  rate  similar  to  decay which  incorporates  natural  cell  death  and also due  to 
innate response. Besides this it can also be destroyed directly or indirectly through the 
effect of T-effector cells.
(iv) Active Vitamin D, [D*], has a tight control over the homeostatic production rate that 
auto-regulates  its  production  by  directly  upregulating  the  activity  of  the  P450 
cytochrome CY24A1. Also, the T-effector cells release cytokines which upregulate 
the activity of P450 cytochrome CYP27B1, which in turn increases production of 
[D*]. 
(v) While T-effector cells are directly inhibited by the increased production of [D*], Treg 
cells  become  up-regulated.   In  addition,  Treg  cells  inhibit  T-effector  cells 
proliferation. 
In the next step we work on coarse-graining the interaction network. This is accomplished 
through making a few simplifying observations and vital assumptions. They are as follows:
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    (a)  Th1, Th2 and Th17 cells are grouped together as Teffector cells. 
   (b) The circulating, inactive form of vitamin D, 25(OH)D3, is generally used as an indication 
of vitamin D status. However, in dendritic cells (DC) use of this precursor depends on its uptake 
by  cells  and subsequent  conversion  by the  enzyme CYP27B1 into  active  1,25(OH)2D3.  As 
1,25(OH)2D3,  the active form of vitamin D, exerts potent effects on the cells of the immune 
system  and  regulating  T  cell  activation,  differentiation  and  migration,  we  have  taken  into 
consideration only the active vitamin D (1,25(OH)2D3) status in DCs. It is represented as [D*]. 
    (c)  [D∗] is assumed to have an overall down regulatory effect on Teffector cells.
   (d)  The T-effector  cells  are  all  downregulated  by regulatory T cells  and all  of them kill 
pathogens.  It  is  assumed  that  T-effector  cells  have  an  overall  upregulatory  effect  on  [D*] 
production. Also noted that, regulatory T cells are promoted by vitamin D and are inhibited as 
[MHC − II] increases (as Treg are upregulated by immature DC).
Figure 2 summarizes the whole course graining method.  
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Figure 2: Coarse-grained network of Figure 1.
 In this diagram for simplicity we consider two loops: (i) Primary loop, (ii) Regulatory loop. Primary loop 
includes pathogen, active APC and effector T-cells. These components are involved in pathogen killing 
process. Regulatory loop have resting APC, Treg cells and vitamin-D.  While regulatory loop inhibits the 
overexcited function of primary loop, primary loop promotes the function of regulatory loop through 
vitamin-D-effector T-cells interaction. Here also green arrows stand for upregulation and red arrows for  
inhibition and black arrow represents conversion processes.   
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Now, some important further assumptions before we set about writing the master equations:
(i) All death rates of T-cells are linear in concentrations.
(ii) The transition probabilities are all assumed to be constant with time but may vary from 
system to system (i.e. here person to person) according to the condition applied. 
Master equations quantifying the reaction network dynamics
Once the following considerations are taken into account, following the coarse-grained network 
for the system as described above, a set of the master equations are written down for the system.
P P P E
dP k T P
dt
σ pi= − −
in
in inP in E a in
dA k A T m A
dt
σ= − −
* *
res
inP in aR R a aD a aE res E inP res a a
dA
k A P k T A k A D k A T k A P m A
dt
= + + − − −
* *a aE res E inP res aR R a aD a a a
dA k A T k A P k T A k A D m A
dt
= + − − −
N
N
T aN a N resN res N N N
dT
k A T k A T m T
dt
σ= − − −
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* *E aN a N ER E R ED E E E
dT k A T k T T k T D m T
dt
= − − −
* *R resN res N RD R R R
dT k A T k T D m T
dt
= + −
D ED E D
dD k T D m D
dt
σ= − −
*
* *ED E D
dD k T D m D
dt
= −
Where the terms signify as follows:
 kij → Transition probability rates, 
kσ → Production rate by body of component k , 
 im  →Overall death rate of component i ,
 P → Pathogen/Antigen/Self-Antigen etc,
 aA → Mature Antigen Presenting Cells,  
inA → Immature Antigen Presenting Cells, 
  NT  →naive antigen-specific T cells,
ET → effector T cells,
RT →regulatory T cells,
D → Inactive form of Vitamin D3 (1, 25(OH)D) in the body 
*D →active form of Vitamin D3 (1, 25(OH)2D) in the body 
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System parameters
The  set  of  nine  coupled  differential  equations  is  very  difficult  to  solve  analytically.  Hence 
numerical methods have to be applied to understand the dynamics of the system. Since accurate 
rate constants/transition probabilities in most of the cases are unknown here, order of magnitude 
estimates for many of the values were employed. [37] In addition, the concentration of precursor 
elements was normalized, so as to reflect manifold change in the production level. Taking typical 
values as mentioned below (see Table 1), the time evaluation of the system and other analyses 
are performed in the present work. 
Table 1: Basic parameter values (*time duration is taken as “days”).
Parameter Symbol Value
Reproduction rate of pathogen
Pσ 1
Death rate of pathogen
Ppi 1
Birth rate of APC
inσ 0.2
Death rate of APC
am 0.2
Rate  of  pathogen  killing  by 
efffector-T cells
Pk 10
Rate  of  APC  activation  by 
pathogen
inPk variable
Rate  of  APC  reactivation  by 
effector T cells
aEk variable
Rate  of  APC  inhibition  by 
regulatory T cells
aRk 1
Rate of APC inhibition by active 
vitamin D
*aDk 10
-2
Birth rate of Native T cells
NT
σ 1
Rate of differentiation of native T 
cell to effector T cell induced by 
aNk 1
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active APC
Rate of differentiation of native T 
cell to regulatory T cell induced 
by resting APC
resNk 1
Mortality rate of native T cell 
Nm 0.01
Rate  of  inhibition  of  effector  T 
cell by active vitamin D
*EDk 1
Rate  of  inhibition  of  effector  T 
cell by regulatory T cell
ERk 0.01
Rate of decay of effector T cells
Em 0.1
Rate  of  regulatory  T  cell 
reactivation by active vitamin D
*RDk 0.01
Rate  of  decay  of  regulatory  T 
cells
Rm 0.1
Production  rate  of  inactive 
vitamin D
Dσ 1
Death rate of inactive vitamin D
Dm 0.1
Rate  of  reactivation  of  active 
vitamin D induced by effector T 
cells
EDk 1.0
Rate  of  deactivation  of  active 
vitamin D
*Dm 1
Results 
Under any sort of pathogenic attack, a healthy immune system always aims at killing 
the foreign antigen by enhancing the proliferation and differentiation rate of its effector T-cells. 
However, the over exceeding number of effector T-cells often fail to distinguish between body’s 
self and foreign peptides and may start destroying self tissues. Thus a healthy immune system 
has to operate within a balanced regulation and the concentration of effector T-cells must be 
controlled so that it can effectively overcome both the pathogenic stimulation and also can resist 
the exploding growth of effector T-cells. Here comes the role of vitamin-D whose optimum level 
effectively  maintains  a  balanced immune regulation.  Vitamin D motivates  regulatory  T-cells 
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activity, as well as vitamin D itself is assigned to reduce the hyper activity of APCs and effector 
T-cells.
In several other model studies only regulatory T-cells are assumed to maintain such 
regulation.  Although  there  are  several  experimental  and  clinical  observations  revealing  the 
important role of vitamin D and its concentration dependent effect in such regulation, we are not 
aware of a single model study that has been employed to study the role of vitamin D. 
Effect of Vitamin-D on T-cells regulation: From weak to strong 
When human body is exposed to certain pathogen of any weak to moderate strength, 
our immune system immediately switches on APC activation and effector T-cells activation. The 
upregulation processes of the regulatory T-cells by resting APC and resting APCs by regulatory 
T-cells as well as upregulation of effector T-cells by active APC and more APC activation by 
effector T-cells play a crucial role is in any strongly or weakly regulated state. [34] However the 
competing behavior of regulatory T-cells and effector T-cells never come to an end in presence 
of antigen because resting APCs are constantly produced by capturing the antigen and APCs are 
activated by antigen stimulation. Thus not only the antagonistic interaction between regulatory 
and effector T-cells activity but their regulation by vitamin-D eventually determine the fate of a 
disease.      
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In the present study we have categorized the regulation into three groups: (i) Strong regulaion, 
(ii) weak regulation and (iii) moderate regulation. To investigate several vitamin-D associated 
factors  we  have  performed  time  evolution  analysis  of  each  participating  element  after  the 
pathogen attack to study their long time behavior. We have studied all these three regulation 
limits both in absence and presence of vitamin-D at different antigenic stimulation. The results 
are shown in Figure 3 are a series of curve for all the three regulation limits, both in the presence 
and absence of vitamin D. The results are quite interesting and we discuss them in more detail 
below.
  In an early study Fouchet and coworker [37] analyzed the steady state values of T-cells in these  
three regulation regimes and showed an interesting and important bistable region at moderate 
regulation regime. We have also observed such bistable region in absence of vitamin-D as shown 
in Figure 3(e) where both strong and weak regulation can coexist. 
Here we find from Figure 3(b) that when system falls under a strong regulation the presence of 
vitamin D shows negligible change compared to a situation when there is no vitamin D (see 
Figure 3(a)). In contrary we observe that in the presence of even a minute amount of vitamin-D 
can convert a weak regulation to a strongly regulated state. (See Figure 3(c) and Figure 3(d)). 
At moderate regulation regime, vitamin D is found to affect the bistable region (see Figure 3(e) 
and Figure 3(f)). In this regime, strong regulation is found to become much stronger, even weak 
regulation is also found to revert towards a strongly regulated state. 
When antigenic stimulation is very high the system always is found to move forward to 
a weakly regulated state where the effector T-cells are abundant. In any situation of Figure 3, we 
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observe  the  crossover  of  T-cell  population  towards  the  high  antigenic  stimulation ( )inPk . 
Depending on the intensity of antigenic stimulation,  system mounts on the required effective 
strong regulation to control the inflammation. This result suggests the important role of vitamin 
need in switching on such effective regulation.   
Figure 3: Variation in T-cell regulation under weak to strong regulation.
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 Steady state concentrations of effector T-cells (shown in blue) and regulatory T-cells (shown in green) 
are plotted against various range of pathogenic stimulation  ( )inPk at the three different APC mediated 
effector T-cell regulation ( )aEk . We find a stable strongly regulated state ( 10)aEk = both (a) in absence of 
vitamin-D and (b) in presence of vitamin-D. The strong regulation remains strong also in presence of  
vitamin-D. An example of stable weakly regulated state 4( 10 )aEk = both (c) in absence of vitamin-D and 
(d) in presence of vitamin-D where weakly regulated state turns to be strongly regulated state up to  
certain pathogenic stimulation 0( 10 1)inPk ≈ = . An example of bi-stable state: 
3( 10 )aEk = (e) where both 
weakly regulated state (shown in solid line) and strongly regulated state (shown in dashed line) can  
coexist in absence of vitamin D. (f) In presence of Viatmin D both the stable states correspond to the  
strongly regulated states. However in the bi-stable situation there always exists an unstable state. Note 
that  strong regulation exerted by vitamin D prolongs for a very high antigenic stimulation.  Here we 
consider the other rate values that are given in Table 1. 
Time evolution of immunological components
In absence of (or at very low concentration) of Vitamin-D
We observed some interesting results from study of the time evolution analysis of the 
immunological components in the above mentioned three regions. Here we have presented the 
dynamical  change  of  elements  against  time  (days)  which  can  quantitatively  explain  some 
attributes of the immune responses both in absence (see  Figure 4) and presence of vitamin D 
(see Figure 5). In Figure 4(a) at around day 2, we see that there is a sudden increase in amount 
of resting APCs (see Figure 4(d)), which reaches a peak very quickly. This, as said before, is 
typically referred to as the onset of the adaptive response. This is in common agreement with 
most  experimental  results  which  suggests  that  the  adaptive  response  sets  in  around  2  days 
(48hours) or so after the pathogenic incursion. [38]
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Around the same time resting APCs start getting activated and we see from the graphs 
in  Figure 4 that  the pathogens  start  dying out  at  a  much faster  rate.  We now have a  huge 
population  of  T-effector  cells  which  have  been  activated  from the  naive  T-cells  after  APC 
activation. 
We also find that once the resting APC has reached its peak level (around 2nd day), 
regulatory T-cells start to raise their production. Once this happens, T-effector cells and APCs 
that have reached a peak are now started to be regulated (around 2nd-5th days). But however when 
pathogen almost die off caused by the tight control exerted by effector T-cells, then resting APCs 
fall in number and regulatory T-cells also follow the same trend as well. Once the Treg cells fall 
down significantly body is then no more tolerant of the pathogen.
 Also, once steady state has been reached after 100 days or so, we can notice that the steady state 
values  of  effector  T cells  (see  Figure S1).  It  has  been clearly  shown in  the  supplementary 
material. This is in accordance with the fact that these cells are antigen specific cells and once 
the pathogen is suppressed, the body creates an immunological memory of the pathogen, which 
corresponds to a steady state value of effector T cells. This is particularly useful, as if the same 
pathogen strikes again, then the amount of antigen specific T cells is higher which would lead to 
a faster and more effective suppression of the pathogen.
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Figure 4: Time evolution of immune response in absence of vitamin D.
 The dynamical variation is calculated in the weakly regulated state as mentioned in Figure 3 in absence  
of vitamin-D.  Adaptive response sets in around 2 days after the pathogenic incursion. Pathogens are  
destroyed around the day 3-4 when effector T-cells reaches its peak value. Although regulatory T-cells 
control a little the huge constant production of T-effector cells, its steady concentration still preserves a  
significantly  large  value  (0.5)  which  may  increase  the  risk  of  autoimmune  diseases.  (Basic  value 
parameters: 40.01, 10inP aEk k= = , other values are taken from Table 1) 
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In the presence of standard level of Vitamin-D 
Vitamin  D  plays  a  crucial  role  in  the  onset  of  adaptive  response.  Nevertheless  it 
modifies the scenario as we have explained in the last subsection. Once the T-effector population 
starts increasing, production of [D*] is upregulated (see Figure 5). This in turn upregulates Treg 
growth  (initiated  at  around  day  3),  which  along  with  [D∗]  regulates  the  aggressive, 
inflammatory responses exerted by T-effector cells, restoring order to the body. As the T-effector 
population decreases (after day 5), the [D*] concentration also starts dipping after reaching a 
maxima.  However  steady  state  has  been  reached  at  around100  days  (see  Figure  S2  in  the 
supplementary material).
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Figure 5: Time evolution of immune response in presence of vitamin D. 
The dynamical variation is calculated in the weakly regulated situation as mentioned in Figure 3 but here  
in presence of vitamin-D.  Adaptive response sets in around 2 days after the pathogenic incursion and 
here  also pathogens are  destroyed around the day 3-4  when effector  T-cells  reaches  its  peak value. 
Subsequently active vitamin D attains its peak value to control over the T-effector cells. Along with the  
enhanced regulatory T-cells production, active vitamin-D itself now control over the large production of 
T-effector cells. The steady state concentration of T-effector cells now low down significantly to a value  
of 0.2 which may decrease the risk of autoimmune diseases.   
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Vitamin D and tolerance
A  healthy  immune  system  is  always  characterized  by  tolerating  certain  extent  of 
pathogenic stimulation. The fact that vitamin D has been implicated as an important factor in 
several different autoimmune diseases suggests that vitamin D might be an essential element that 
normally participates in the control of self-tolerance. [39] From the model we explain that how 
the presence of vitamin-D can assist to attain a strongly regulated state that can reduce the risk of 
autoimmunity. We have considered here the moderately regulated/bistable regime as described in 
Figure 3(e) and  3(f). It is worth to mention here that experimental observations related to the 
adoptive transfer of tolerance also supports the emergence of such bistability where the balanced 
co-existence of strong and weakly regulated immune response preserve in the system. [40] Note 
that  while  strongly  regulated  state  critically  referred  to  system’s  tolerance  for  a  certain 
pathogenic stimulation, weak regulation always mount system’s response against that pathogen. 
Weak  or  strong  regulation  crucially  depends  on  the  growth  rate  of  T-effector  as  well  as 
regulatory T-cells population. However the steady state population of Treg or T-effector cells is 
inversely related to their death rates. To investigate how the death rate of effector T-cells ( )Em
and death rate of regulatory T-cells  ( )Rm  mutually determine the mode of regulation we have 
varied both of them simultaneously. We have performed similar analyses as Figure 3 to find out 
how a regulation is tuned between strong and weakly regulated states. Here in Figure 6(a) we 
observe that in absence of vitamin D, system is more tolerant towards the low death rate of 
regulatory T-cells which leads to a more steady state population of regulatory T-cells. However 
in presence of vitamin D as shown in  Figure 6(b) we find a considerable enhancement of the 
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tolerance level. Vitamin D still maintains the tolerant response even though there is high death 
rate of regulatory T-cells.     
Figure 6: Vitamin D induced tolerance level (emergence of strong regulation). 
Here we have varied both death rate of effector T-cells ( )Em and death rate of regulatory T-cells ( )Rm  to 
study the regulation in terms steady state concentration of regulatory and effector T-cells. Basic value 
parameters are taken as in given Figure 1(c) (also see Table 1) so that we are in the bi-stable regulation  
region. Initially, there are no effector T cells. Here pink zone correspond to the tolerance, i.e. the system 
falls into the strongly regulated state. Cyan zone corresponds to the development of a strong immune  
response,  i.e.  the  system  falls  into  the  weakly  regulated  state.  (Basic  value  parameters:  
30.01, 10inP aEk k= =  , other values are taken from Table 1).
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Steady state analysis and optimal vitamin D
Similar to immune network theory [41] we have also assumed that the system has a large 
number  of  stable  steady  states  that  depends  on  several  conditions  that  includes  pathogen 
concentration, strength of stimulation, vitamin D concentration, APC activation rate and other 
various transition probabilities. Nevertheless the system can switch between two different steady 
states as has been often observed experimentally. For instance, low or high doses of an antigen 
can cause the system to switch to a suppressed state for the antigen, while intermediate doses can 
cause the induction of immunity. However in any particular condition system ultimately reaches 
to its steady state. 
In steady state, for the present case, the body is assumed to be under the following constraints:
No Pathogenic incursion, so the entire pathogen term drops to zero.  There are no T-effector 
cells. There are no resA or aA , i.e. mature APC cells. All DC's are immature or inactive.
Under the above constraints, the system of equations reduces to, at steady state:
0in in inP in E a in
dA k A T m A
dt
σ= − − =
0N N aN a N resN res N N N
dT k A T k A T m T
dt
σ= − − − =
0D ED E D
dD k T D m D
dt
σ= − − =
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Solving these equations simultaneously, we get the following relations:
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From the steady state relations, we can draw some important observations that make relevance to 
the state of the immune system. As assumed before, since all rate constants are time-invariant, 
we can see that the only variables are the production rates i.e. σ  values and death rates i.e. m
values that can only modify the steady state concentration of the precursor elements. However in 
absence  of  pathogen in  the  present  case,  we obtain  the  steady state  concentration  value  for 
vitamin-D is 10. 
Vitamin D as a modulator
One important detail which needs to be addressed is the apparently new steady state in 
presence of pathogen in production of vitamin D with its  tightly  controlled  homeostasis.  To 
understand the relevance of vitamin D in the above response, different initial concentrations of 
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vitamin  D  were  taken  to  investigate  its  role.  We  have  basically  considered  the  initial 
concentrations of vitamin D near the steady state value of vitamin-D. 
A range of concentrations from 10−2 to 103 were taken (initially normalized to 10 in analysis in 
previous section) and the pathogen levels, T-cell levels and APC levels were noted in the newly 
established steady state. Steady state concentration of each element is plotted versus log([D ]. 
Very interesting results are observed (see Figure 7). 
Figure 7: Steady state value analyses as a function of log(initial vitamin D levels). 
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At certain range of vitamin D concentration (around the value vitamin-D concentration 10) system gear 
up a more strong regulation where the steady state value of T-effector cells start on deceasing even with a  
faster rate. As a result pathogen concentration makes a sudden move towards its higher value to reappear 
back to the system. Note that at around vitamin-D concentration 100, each component shows a blast i.e., 
the concentration of the components decreases or increases very fast. However we indicate (with a green  
limit  bar)  the optimal vitamin-D ranges around 10-50 where both pathogen and effector T-cell  level  
remain at reasonably low value. Vitamin-D level 100 corresponds to an alarming concentration compared  
to the standard vitamin D limit. 
We indicate the optimal Vitamin-D level around 10-50 where both pathogen and effector T-cell 
level remain at reasonably low value. Recently a large number of epidemiological studies and 
an U.S. Institute of medicine committee start to shed light on various studies related to vitamin 
D. [42, 43] They reported that a serum 25-hydroxyvitamin D level of 20 ng/mL (50 nmol/L) is 
desirable for bone and overall health. Those studies indicated both the upper and lower limit of 
vitamin  D  intake.  The  high  IgE levels  were  seen  at  very  low 25-hydroxyvitamin  D3  (<25 
nmol/L) and at very high 25-hydroxyvitamin D3 (>135 nmol/L) levels. [44]
If we quantify the optimal level of vitamin D in the unit of nmol/lit, we are in the right ball park  
number.  
We study the variation of each element around this optimal range. 
Pathogen: We  see  that  there  is  no/negligible  amount  of  pathogen  remaining  for  all 
concentrations of vitamin D below standard levels.  This is  because,  less the vitamin D, less 
regulatory  the  system is  and  hence  more  aggressive  is  the  immune  response.  This  leads  to 
complete  eradication  of  pathogen.  As  vitamin  D  levels  start  being  higher,  the  regulatory 
mechanism is highly upregulated leading to a more tolerant response. This can be noticed from 
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the fact that beyond homeostatic standard levels, pathogen concentrations are not tends to zero 
and grow as a function of log [D].
APC: Below homeostatic levels, we see that the concentrations of inactive, active and resting 
APCs are largely invariant and constant. As we increase the concentration of vitamin D near the 
optimal  level  (100)  the  active  APC reaches  to  its  peak  value.  This  is  because  there  is  no 
inhibition of activation of APC from very low concentrations of vitamin D. This suggests that 
there  is  constant  T-cell  activation,  leading  to  a  more  inflammatory  response  at  lower 
concentrations of vitamin D. At higher concentration of vitamin D, there is strong inhibition of 
active APCs and a strong decline of active APC concentration is seen. In contrary beyond the 
optimal level of vitamin D regulatory T-cell grows rapidly as function of log [D]. This offers a 
more  tolerant  response  as  the  ability  to  activate  T-effector  cells  is  lesser.  The  result  again 
suggests that at low vitamin D concentrations, inflammatory responses are more likely, which is 
a plausible cause for an increased risk of autoimmune response.
 Naive T cell: The switch like behavior around homeostatic concentrations is noted. The reason 
for higher antigen specific T cells at lower vitamin D concentrations would indicate a higher 
probability of inflammation at low vitamin D levels. This is again in tune with the experiments 
that suggest vitamin D deficiency may be linked to autoimmune responses.
T-effector cell: Since T-effector cells are obtained from the activation of a naive T cell by an 
active APC, we see that the populations behave similar to those of native T-cells. The reasoning 
would be the same as for the APCs. 
T-reg cells: Near the optimal  range of vitamin D, an elevated level  of regulatory T cells  is 
buttoned on. This suggests that at the optimum vitamin D level there is an increased localized 
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production  of  [D*] which serves  to  upregulate  population  of  regulatory  T cells  by the  time 
adaptive response sets in.
Sensitivity to the values of parameters 
Scanning of Vitamin-D related basic value parameter
Because  of  the  lack  of  information  of  the  precise  values  of  vitamin-D  related  rate 
constants it is crucial to investigate both the robustness and the sensitivity to these values. An 
additional reason for this study of the sensitivity is that these values change from system to 
system  (here  person  to  person)  and  the  values  can  fluctuate  even  for  the  same  person 
depending on the various conditions.  
As both the T-cells i.e. Treg and T effector cells are modulated by the impact of active 
vitamin-D we have investigated the outcome of different possibilities of the combination of 
*RDk and *EDk . Here we have scanned their parameter space to find the safe zone where both 
the  pathogen  and effector  T-cells  concentration  remains  under  control.  However  at  high 
vitamin  D  impact  parameter  pathogen  may  largely  enhance  their  growth.  Here 
( )* *log , logED RDk k  parameter  space  suggests  that  we  should  not  exceed  the  value  of 
* *log 0.1, log 0.1RD EDk k= =  to  attain  a  safe  zone  (see  Figure  8(a)).  However 
( )*log , logED EDk k  parameter  space suggests that  we should stay behind the region where 
*log 1, log 2ED EDk k= = to avoid high pathogenic raise up (see Figure 8(b)).
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Figure 8: Basic value parameter scan.
 Investigation of vitamin-D impact- (a) Over regulatory T-cells up-regulation ( )*RDk  and effector T-cells 
down-regulation rate ( )*EDk , simultaneously in their parameter space, and (b) over effector T-cells down-
regulation rate ( )*EDk and effector T-cell initiated active vitamin-D production rate ( )EDk  simultaneously 
in  their  parameter  space.  ( )* *log , logED RDk k parameter  space  suggests  the  value
* *log 0.1, log 0.1RD EDk k= =  is the alarming zone beyond which pathogen may retain in the system. 
( )*log , logED EDk k  parameter space suggests the value  *log 1, log 2ED EDk k= =  is the alarming zone 
beyond which effect of vitamin-D is carcinogenic that allow reappearance of a large amount of pathogen.  
Here we have taken weak pathogen stimulation ( )0.0001aPk = while other parameter values are taken 
from Table 1.
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Weak simulation and strong regulation: A specific regime
Each day each moment immune system protects us against millions of hazardous foreign 
elements. Whether the pathogenic stimulation strong or weak a healthy immune network always 
maintains  a  balanced regulation  over  the T-effector  cells  concentration  to  reduce  the risk of 
autoimmunity. We are aware of the fact that while presence of vitamin-D at its standard level is 
required  to  control  the  effector  T-cell  explosion,  above a  threshold  vitamin-D concentration 
causes  reappearance  of  the  pathogen  above  the  tolerance  level  of  our  immune  system.  To 
investigate such possibilities we have evaluated the pathogen concentration varying the negative 
impact  of  [D*]  over  APCs  ( )*aDk and  effector  T-cells  ( )*EDk simultaneously.   We  find 
interestingly  three  regions  (see  Figure  9(a))  (i)  safe  zone  at  low  vitamin-D impact,  where 
pathogen concentration is found to be negligible, (ii) pathogen reappearance zone, where initially 
pathogen  concentration  becomes  lower  by  the  peak  value  concentration  of  effector  T-cells. 
However at  longer time pathogen and effector T-cells  shows a damping oscillation but both 
waves move in an anti-correlated fashion and finally reach their steady state values. (see Figure 
9(b)).  This  oscillation  supports  the  normal  tolerance  to  pathogen  and  the  remaining  T-cells 
preserves  the long term memory of  the  past  attack.  These combinations  support  the  regular 
defense mechanism by which our  immune system works.  (iii)  In  the third region we find a 
pathogen sustaining zone where at high vitamin-D impact system is hyper regulated and steady 
state concentration value of pathogen remains significantly large. 
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Figure 9: Impact of vitamin-D over pathogenic profile. 
(a) We vary simultaneously the impact of [D*] over APCs ( )*aDk and effector T-cells ( )*EDk . We find 
three different regions: safe zone where pathogens are low in concentration. Reapperance of pathogen 
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occurs at moderate vitamin-D impact imposed on active APC and effector T-cells. At high vitamin-D  
impact  steady state  concentration  of  pathogen  largely  increases.  (b)  At  pathogen reappearance  zone 
effector T-cells and pathogen propagates with a damping oscillation and reaches to their steady state  
values  at  longer  time.  Here  we  have  taken  weak  pathogen  stimulation  and  strong  effector  T-cell  
regulation ( )0.0001, 10inP aEk k= = while other parameter values are taken from Table 1.
Discussion
Vitamin D, the “Sunshine Vitamin” is now well recognized for the immunomodulatory 
functions  beyond  its  classical  function  in  calcium  metabolism. To  understand  the  immune 
regulation exerted by vitamin D in this  study we develop a theoretical coarse-grained model 
based on interaction network. The network dynamically connects different immune components 
that are involved in the vitamin D regulated immune responses. The formulated kinetic scheme 
describes  time evolution of these components  that include pathogen, APCs, effector  T cells, 
regulatory  T  cells,  etc.  The  steady  state  analyses  of  the  proposed  master  equations  suggest 
intricate relations between vitamin D levels and regulatory T cells maintained by homeostasis 
where vitamin D play role as a strong regulatory activator. We found quantitatively that lower 
levels of concentration of active vitamin D ([D*]) (lower than optimum) correspond to weak 
regulation.  In  this  limit  once a  pathogen/antigen  enters  the  body,  the  nature  of  the immune 
response would be more inflammatory. This eventually leads to autoimmune diseases. On the 
other hand our model predicts that vitamin D enhances the tolerance level of immune system, 
thereby increasing resistance to auto-immune diseases. Quantitative predictions of the model are 
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in good agreement with several other experimental studies and clinical observations. Our model 
essentially attempts to quantify how much vitamin D is needed to resist autoimmunity and why.
The steady state analysis of the proposed master equations revealed intricate relations 
between vitamin D levels  and T-regulatory cells  maintained by homeostasis.  These relations 
suggested that  at  homeostasis,  lower  levels  of  [D*] correspond to  a  lower population  of  T-
regulatory cells, which suggests that once a pathogen/antigen enters the body, the nature of the 
immune  response  would  be  less  regulatory  and  hence  more  inflammatory(aggressive).  The 
simulations seem to be in fair agreement with the typical progression of an immune response. 
The  critical  role  of  the  various  cells,  especially  localized  [D*]  concentration  is 
understood via investigating the dynamics of the response. This was done through simulating the 
coupled  differential  equations.  Further,  there  exists  a  delicate  window  of  concentrations  of 
vitamin  D  which  would  be  critical  in  maintaining  an  appropriate  response  to  a  pathogen. 
Extremely  low  levels  of  [D*] could  lead  to  increased  risk  of  autoimmune  responses  and 
extremely high levels would suggest an extremely tolerant response, which could increase the 
risk of tumors and cancerous cell growth. 
It is important to note that two enzymes CYP27B1 and CYP24A1 and the population of VDR 
play important role in balancing several immunological responses. Our coarse-graining model 
would predict that defect/unavailability of any of these proteins will greatly perturb the whole 
system. A series of D*-VDR mediated processes that have enormous consequences have not 
been fully understood yet. Malfunction of these enzymes (such as: CYP27B1 and CYP24A1) can 
also reflect a deeper problem that is difficult to rectify.   
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It  is  worth  mentioning  here  that  the  activation  of  a  naive  T  cell  into  an  effector  or 
regulatory T cell is a complex process. This begins with the scanning of the surface of the APC's 
in the lymph nodes for the MHC class II type molecules by the naive T cells. If a particular  
epitope is recognized and co-stimulatory molecules are present, then the activation process is 
initiated. Now this can be understood via an energy landscape analysis. The process of successful 
activation can be thought of as the T cell negotiating a barrier in the energy landscape. This can 
be brought about through either a single successful contact with an APC or multiple contacts if 
the second or later contact occurs within a finite time. If the T-cell is above the seperatrix in the 
energy landscape then the probability of a successful activation is higher which is only present 
for a finite time after the previous excitation. This is very similar to the immunological studies 
carried out by Hong et al.  [45] and Chakraborty et  al.  [46] and the enzyme catalysis  model 
proposed by Min, Xie and Bagchi earlier. [47] However to make the present model tractable, we 
had to ignore such complexity of T-cell activation. 
The  master  equation  approach  adopted  here  gives  a  deterministic  description  of  the 
problem, given the initial values of the parameters and the fluxes.  Within a biological cell, there 
can always be large fluctuations due to environmental factors or other causes. [48, 49] Such 
fluctuations can induce cross-over from weak regulation to strong regulation.
In future, we plan to extend our system of equations to include effects of drugs such as 
immune suppressants such as glucocorticoids that introduce a further competition in the reaction 
network of the body. The role of immune suppressants is not understood but known to exhibit 
serious side effects like cancer.
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